Program Book

Name

Disclosure Entity

Disclosure Type

Presentation Number

Leite, Maria F.

CNPq, CAPES, FAPEMIG

Other

1554-Pos 1223-Plat

Lembong, Josephine

Firmenich Inc. Aratome LLC

Research funded by industry grant

Lenzi, David

Ownership or Partnership in funding organization 2012-Pos

Li, Tong

Medimmune LLC

Research funded by industry grant

3292-Pos

Liao, Jinfang

Full time employment with AAT Bioquest

Employment (full or part-time) in funding company 1859-Pos

Lilja, Kaisa E. Liu, Gongxin

Biolin Scientific Gilead Sciences

Employment (full or part-time) in funding company 3153-Pos Employment (full or part-time) in funding company 1664-Pos

Liu, Fei

Bill & Melinda Gates Foundation Research funded by industry grant

2108-Pos 3292-Pos

Livesay, Dennis R.

Medimmune LLC

Research funded by industry grant

Lo, Michael

Anasys Instruments Corp. Full time employee of Sophion

Employment (full or part-time) in funding company 1033-Pos Employment (full or part-time) in funding company 2746-Pos

Løjkner, Lars D.

Lopaschuk, Gary D.

Metabolic Modulators Research Ltd Stock options or bond holdings in a for-profit corporation or self-directed pension plan

945-Pos

Luerman, Greg

ChanTest

Employment (full or part-time) in funding company 3647-Pos

Ma, Jianjie

TRiM-edicine, Inc

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

503-Pos

Ma, Jianjie Ma, Jianjie

Founder of TRIM-edicine

Other Other

3201-Plat 3687-Pos

Dr. Jianjie Ma has equity interest in TRIM-edicine, Inc. that is developing MG53 as a regenerative medicine agent.

Magdeleine Hung, Magdeleine

Gilead Sciences Inc.

Employment (full or part-time) in funding company 1330-Pos

Malkin, Gene

PathoGenetix

Employment (full or part-time) in funding company 1419-Pos

Manara, Richard

Oxford Nanopore Technologies Co-founder and owner: ActoSense Biotech AB

Research funded by industry grant

2227-Plat 2289-Plat

Mansson, Alf

Other

Markova, Natalia Mayer, Michael Mayer, Michael Meltzer, Robert H. Metzger, Joseph M.

GE Healthcare

Employment (full or part-time) in funding company 1529-Pos

Oxford Nanopore Oxford Nanopore

Research funded by industry grant Research funded by industry grant

1080-Pos 1081-Pos

PathoGenetix

Employment (full or part-time) in funding company 1419-Pos

Phrixus Pharmaceuticals

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

3867-Pos

Miller, William Minner, Daniel E.

GlaxoSmithKline

Employment (full or part-time) in funding company 3267-Plat

Indiana University-Purdue University Indianapolis, Integrated Nanosystem Development Institute, Indianapolis

Other

873-Pos

Mitlo, Trisha

Molecular Devices, LLC Schrodinger Software NSF Career Award Nanion Technologies Nanion Technologies

Employment (full or part-time) in funding company 681-Pos Consulting fees or other remuneration from industry 1265-Plat

Mobley, David L.

Mofrad, Mohammad R.

Other

1208-Plat

Mueller, Max Mumm, Patrick Nguyen, Steven

Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 1664-Pos Employment (full or part-time) in funding company 1419-Pos Employment (full or part-time) in funding company 2377-Pos

Gilead Sciences PathoGenetix

Nicholson, Andrew

Niedziela-Majka, Anita Gilead Sciences

294

Biophysical Society 58 th Annual Meeting, San Francisco, California